RVL Pharmaceuticals plc (RVLPQ)

RVL Pharmaceuticals Revenue

RVL Pharmaceuticals had revenue of $8.26M in the quarter ending June 30, 2023, a decrease of -2.25%. This brings the company's revenue in the last twelve months to $36.92M, up 5.64% year-over-year. In the year 2022, RVL Pharmaceuticals had annual revenue of $49.72M with 184.10% growth.

• Revenue (ttm): 36.92M
• Revenue Growth: +5.64%
• P/S Ratio: n/a
• Revenue / Employee: 295.35K
• Employees: 125
• Market Cap: 111.00

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	49.72M	32.22M	184.10%
Dec 31, 2021	17.50M	-10.26M	-36.96%
Dec 31, 2020	27.76M	-212.27M	-88.43%
Dec 31, 2019	240.03M	-23.67M	-8.98%
Dec 31, 2018	263.70M	17.95M	7.31%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2023

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 22, 2026

Data Sources Report a data error